Opinion | October 29, 2021
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
It plans to double its network to 50 centres across India in the next three years
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
The combined entity will have 12 hospitals with 3,666 beds
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
